Key result
Chelating anticoagulants significantly reduce plasma doxycycline concentrations, impacting accurate measurement for doxycycline PEP adherence monitoring.
Why the study?
Accurate doxycycline measurements are needed to consistently evaluate adherence and efficacy of doxycycline post-exposure prophylaxis.
Do chelating anticoagulants reduce plasma doxycycline measurements compared to non-chelating anticoagulants?
Do chelating anticoagulants reduce plasma doxycycline measurements compared to non-chelating anticoagulants?
Pharmacokinetic studies of doxycycline should prioritize blood collection in non-chelating anticoagulants to avoid artificially reduced plasma concentration measurements.
Answers are grounded in this paper and cite their sources.
May artifactually lower measured doxycycline levels; leaves open accurate PEP adherence monitoring.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Daly et al. (2026) studied this question. Chelating anticoagulants significantly reduce plasma doxycycline concentrations, impacting accurate measurement for doxycycline PEP adherence monitoring.
Synapse has enriched 10 related papers. Consider them for comparative context: